Loading…
Context Therapeutics Inc. is projected to rise to $3.71 by 2027, a +24% move from its current price of $2.98. CNTX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $2.85 | $2.98 | $3.12 | -0.01% |
| May 30 | $2.79 | $2.98 | $3.18 | -0.01% |
| May 31 | $2.75 | $2.98 | $3.22 | -0.02% |
| Jun 1 | $2.72 | $2.98 | $3.26 | -0.03% |
| Jun 2 | $2.69 | $2.98 | $3.30 | -0.03% |
| Jun 3 | $2.67 | $2.98 | $3.33 | -0.04% |
| Jun 4 | $2.64 | $2.98 | $3.36 | -0.04% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.64 | $2.98 | $3.36 | -0.04% |
| Week 2 | $2.51 | $2.98 | $3.53 | -0.09% |
| Week 3 | $2.42 | $2.98 | $3.66 | -0.13% |
| Week 4 | $2.34 | $2.97 | $3.78 | -0.18% |
| Week 5 | $2.28 | $2.97 | $3.89 | -0.22% |
| Week 6 | $2.22 | $2.97 | $3.98 | -0.26% |
| Week 7 | $2.16 | $2.97 | $4.08 | -0.31% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Context Therapeutics Inc. (CNTX) is a clinical-stage biopharmaceutical company focused on treatments for solid tumors. Its product candidate CTIM-76 is a Claudin 6 (CLDN6) x CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
It has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.
CNTX is currently trading in the healthcare sector with a current price of $2.98 and a market cap of $273.8M. It holds a rank of 3561. The long-run price outlook, as captured in the provided forecast, points to meaningful upside, with the average price rising from $2.98 in 2026 to $7.55 by 2030, then to $24.65 by 2040 and $47.90 by 2050, accompanied by substantial ROIs of 153.4%, 727%, and 1507.3% respectively.
A major floor 51.7% below — a decisive break under it would weaken the trend.
The nearest floor, 27.9% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 18.6% above — clearing it would confirm fresh momentum.
Key CNTX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CNTX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.57 | Buy | $2.64 | Buy |
| MA 10 | $2.40 | Buy | $2.51 | Buy |
| MA 20 | $2.39 | Buy | $2.44 | Buy |
| MA 50 | $2.51 | Buy | $2.43 | Buy |
| MA 100 | $2.37 | Buy | $2.26 | Buy |
| MA 200 | $1.72 | Buy | $1.91 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 69.36 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 318.08 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.07 | Buy |
| ROC (12) | 25.21 | Buy |
| Bollinger %B (20,2) | 1.31 | Sell |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | -0.21 | Sell |
| Awesome (5,34) | 0.17 | Buy |
| Ultimate (7,14,28) | 85.55 | Sell |
| Momentum (10) | 0.50 | Buy |
| Aroon Osc (25) | 24.00 | Buy |
| Hull MA (9) | 2.79 | Buy |
| ADX (14) | 14.07 | Neutral |
| ATR (14) | 0.11 | Info |
The near-term technical picture is bullish, with RSI14 at 70. The price is above the SMA50 of $2.51 and above the SMA200 of $1.72, suggesting positive momentum. Key levels include support at $2.15 and resistance at $2.98. The 30-day range spans from $2.21 to $4.02, indicating room for movement within a bullish setup.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.44 | $2.98 | $3.88 | 0% | Neutral | |
| $2.75 | $3.71 | $5.38 | +24% | Bullish | |
| $3.69 | $5.21 | $7.98 | +75% | Bullish | |
| $4.75 | $7.00 | $11.18 | +135% | Bullish | |
| $4.94 | $7.55 | $12.49 | +153% | Bullish | |
| $4.93 | $7.81 | $13.31 | +162% | Bullish | |
| $5.74 | $9.40 | $16.47 | +215% | Bullish | |
| $5.53 | $9.33 | $16.76 | +213% | Bullish | |
| $6.80 | $11.85 | $21.75 | +298% | Bullish | |
| $9.48 | $17.01 | $31.88 | +471% | Bullish | |
| $11.94 | $24.65 | $50.30 | +727% | Bullish | |
| $21.55 | $47.90 | $110.17 | +15.1x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.44 | $2.98 | $3.53 | +0.00% |
| June 2026 | $2.45 | $2.91 | $3.58 | -2.23% |
| July 2026 | $2.45 | $2.96 | $3.72 | +1.70% |
| August 2026 | $2.54 | $3.10 | $3.96 | +4.56% |
| September 2026 | $2.42 | $2.99 | $3.87 | -3.55% |
| October 2026 | $2.25 | $2.80 | $3.67 | -6.42% |
| November 2026 | $2.27 | $2.84 | $3.77 | +1.73% |
| December 2026 | $2.30 | $2.90 | $3.88 | +1.97% |
Click any year to see its month-by-month CNTX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, CNTX could reach as high as $3.88, with a base case around $2.98 and support toward $1.44 — roughly 0% from $2.98. Price action looks broadly range-bound.
Expect CNTX to range from $2.75 to $5.38 through 2027. The $3.71 average target implies a +24% move from current prices. That is up +24% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The CNTX price prediction for 2028 points to an average of $5.21 (low $3.69, high $7.98) — a potential gain of +75% on today's $2.98. Momentum favours further upside here.
In 2029, CNTX is projected to trade between $4.75 and $11.18, averaging $7.00 — a potential gain of +135% from today's $2.98. That is up +34% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Context Therapeutics Inc.'s 2030 outlook centres on $7.55, within a $4.94 to $12.49 range. That is up +8% on the projected 2029 average. That marks a +153% change versus current levels. Momentum favours further upside here.
By 2031, CNTX could reach as high as $13.31, with a base case around $7.81 and support toward $4.93 — roughly +162% from $2.98. Buyers look set to stay in control over this stretch.
Expect CNTX to range from $5.74 to $16.47 through 2032. The $9.40 average target implies a +215% move from current prices. That is up +20% on the projected 2031 average. Momentum favours further upside here.
The CNTX price prediction for 2033 points to an average of $9.33 (low $5.53, high $16.76) — a potential gain of +213% on today's $2.98. Buyers look set to stay in control over this stretch.
In 2034, CNTX is projected to trade between $6.80 and $21.75, averaging $11.85 — a potential gain of +298% from today's $2.98. That is up +27% on the projected 2033 average. Momentum favours further upside here.
Context Therapeutics Inc.'s 2035 outlook centres on $17.01, within a $9.48 to $31.88 range. That is up +44% on the projected 2034 average. That marks a +471% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, CNTX could reach as high as $50.30, with a base case around $24.65 and support toward $11.94 — roughly +727% from $2.98. Momentum favours further upside here.
Expect CNTX to range from $21.55 to $110.17 through 2050. The $47.90 average target implies a +15.1x move from current prices. That is up +94% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in CNTX today (≈ 335.57047 CNTX) could be worth
$16,073.18
+$15,073.18 (+1507%) by 2050 · US Dollar
Based on the average projected CNTX price of $47.9 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CNTXwould be worth at today's price.
$1,000 invested in CNTX on May 27, 2025 (≈ 1,468.428794 CNTX) would be worth
$4,375.92
+$3,375.92 (+337.6%) today · 4.38× · US Dollar
Based on a CNTX entry price of $0.681 vs. today's $2.98.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.23 | $1,336.32 | +33.6% |
| 1 month ago | $2.34 | $1,273.5 | +27.4% |
| 3 months ago | $2.28 | $1,307.02 | +30.7% |
| 6 months ago | $1.12 | $2,660.71 | +166.1% |
| 1 year ago | $0.681 | $4,375.92 | +337.6% |
| All time (4.6y) ago | $5.1 | $584.31 | -41.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CNTX forecast.
Our base-case forecast reaches $6.00 around 2029.
Implied market cap at $6.00: $551.28M
The multi-year forecast shows bullish sentiment across the horizon. In 2026, the avg is $2.98 (ROI 0%, sentiment NEUTRAL). By 2027, the avg rises to $3.71 (ROI 24.4%, bullish); by 2028 to $5.21 (ROI 74.9%, bullish); by 2029 to $7.00 (ROI 135%, bullish).
The 2030 forecast sits at an avg of $7.55 with a max of $12.49 and ROI of 153.4% (bullish). In later years, the avg climbs to $7.81 (2031), $9.40 (2032), $9.33 (2033), $11.85 (2034), and $17.01 (2035), with continued bullish sentiment and higher ROIs. The path extends to 2040 (avg $24.65, ROI 727%) and 2050 (avg $47.90, ROI 1507.3%), underscoring a long-run upside potential while recognizing these are estimates, not guarantees.
Drivers and risks are inherent in such forecasts and should be considered with caution.
Tap a question to reveal the answer.
2030 avg $7.55; max $12.49; ROI 153.4%; sentiment BULLISH.
Forecasts show bullish sentiment from 2027 onward with increasing average prices; 2026 avg is $2.98 (ROI 0%) and sentiment NEUTRAL, with substantial upside projected through 2030, 2040, and 2050.
Yes. The 2029 max is $11.18.
Current price is $2.98 and market cap is $273.8M.
Low $2.21, high $4.02.
Context Therapeutics Inc. Community Discussion
0Share your Context Therapeutics Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.